Category: Latest News
-
ClearPoint Neuro Shares Fall 24% Following uniQure AMT-130 Trial Update
ClearPoint Neuro (NASDAQ:CLPT) shares fell 24% on Tuesday following updated clinical trial results from partner uniQure N.V. (NASDAQ:QURE) for its experimental Huntington’s disease gene therapy. uniQure shares declined 55% after the company reported updated data for ifezuntirgene inilparvovec, also known as AMT-130. The treatment did not achieve statistical significance on a primary clinical measure at…
-
Alaska Air Group Sets 2030 Growth Targets at Investor Day
Alaska Air Group (NYSE:ALK) outlined the next phase of its Alaska Accelerate strategic plan at its 2026 Investor Day in Seattle, including targets for premium travel, international routes, loyalty, cargo and fleet expansion. The company described the next stage of the plan as an “activation” phase following integration work associated with its acquisition of Hawaiian…
-
Bell Canada and Cisco Sign MOU to Develop Sovereign AI Infrastructure Offering
Bell Canada (BCE) and Cisco (NASDAQ:CSCO) have signed a memorandum of understanding to collaborate on a sovereign artificial intelligence infrastructure offering for customers in Canada. The proposed offering will combine Bell’s Canadian data centre, network and operational capabilities with Cisco’s AI, security, observability, infrastructure monitoring and management technologies, including its Sovereign Critical Infrastructure portfolio. The…
-
Voyager Technologies Shares Rise 6% After Anduril Partnership Announcement
Voyager Technologies (NYSE:VOYG) shares rose 6% on Tuesday after the company announced a strategic partnership with Anduril Industries covering the development and production of weapons systems and missile defence technologies. The agreement formalises an existing collaboration between the two companies across multiple weapons programmes, including several initiatives identified as priorities by the US Department of…
-
Cboe Shares Rise 5% After Extending S&P 500 Licensing Agreement Through 2051
Cboe Global Markets (AMEX:CBOE) shares rose 5% after the company announced a 25-year extension of its exclusive licensing agreement with S&P Dow Jones Indices, continuing the relationship through 2051. The agreement maintains Cboe’s exclusive rights to offer trading in its S&P 500 Index (SPX) options and provides scope for the companies to develop additional products…
-
FuelCell Energy Shares Rise After Oppenheimer Initiates Coverage With Outperform Rating
FuelCell Energy (NASDAQ:FCEL) shares rose 9% in premarket trading on Tuesday after Oppenheimer initiated coverage of the company with an Outperform rating and a $24 price target. Analyst Colin Rusch cited FuelCell Energy’s exposure to demand for on-site power generation from the expanding data centre market, describing the company as a “differentiated provider” of firm,…
-
US Futures Edge Higher as Oil Prices and Treasury Yields Pull Back: Dow Jones, S&P, Nasdaq, Wall Street
US stock futures pointed to a modestly higher open on Tuesday, with a decline in crude oil prices and a pullback in Treasury yields following losses for the major Wall Street indexes in the previous session. US crude oil futures fell more than 2%, reversing part of Monday’s increase. Oil prices declined despite limited progress…
-
UPS Partners With TikTok Shop for No-Box, No-Label Returns Service
UPS (NYSE:UPS) has entered into a partnership with TikTok Shop to provide an exclusive no-box, no-label returns service for participating sellers on the social commerce platform in the United States. The service will be provided through Happy Returns, allowing TikTok Shop customers to return eligible products without packaging or printed shipping labels. The partnership expands…
-
Meta Expands Muse AI Agent to Small Businesses With New Software Integrations
Meta Platforms (NASDAQ:META) is expanding its Muse artificial intelligence agent to small businesses, adding integrations with a range of commerce, accounting, payments and productivity platforms. The expansion allows Muse for Small Business to connect with tools including Shopify, QuickBooks, Stripe and Canva, as Meta seeks to extend the AI agent into business operations and broaden…
-
Novo Nordisk Reports Real-World Semaglutide 2 mg Cardiovascular Analysis Versus Tirzepatide
Novo Nordisk (NYSE:NVO) presented retrospective real-world evidence comparing cardiovascular outcomes among adults with type 2 diabetes who increased their once-weekly semaglutide injection from 1 mg to 2 mg with those who switched from semaglutide to tirzepatide. The analysis, presented at the European Association for the Study of Diabetes Annual Meeting 2026 in Milan, Italy, included…